Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06553131 · ClinicalTrials.gov registry record
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
A clinical trial of Neuromuscular Blockade, sponsored by Loma Linda University.
- Recruiting
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT06553131 is a study of Neuromuscular Blockade that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 32 participants, below the 11,836-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06553131, a study of Neuromuscular Blockade, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Medications used to relax the muscles are used during surgery. The amount of muscle relaxation can monitored with devices that stimulate a specific nerve and evaluate the muscle response. The response to, and recovery from, medications that relax the muscles are best described for a nerve in the arm called the ulnar nerve. The investigators believe that other nerves in the arm, such as the median nerve, could be used to monitor the amount of muscle relaxation. The purpose of this study is to compare the muscle response at two different nerve sites after giving medications to relax the muscles. This study is going to measure the depth of muscle relaxation during surgery at two different sites. The muscle response to stimulation of the ulnar nerve (located in the arm) will be compared to the muscle response to stimulation of the median nerve (also located in the arm).
Conditions Studied
Interventions
- DEVICE Neuromuscular Transmission Monitoring
Study Locations (1)
California
- Loma Linda University Troesch Medical Center - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-12-26 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06553131
The ClinicalTrials.gov registry entry for NCT06553131 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 11,836-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (100% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuromuscular Blockade appearing as the primary indexed condition, and to 1 intervention - of which Neuromuscular Transmission Monitoring is the first listed.
NCT06553131 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06553131 about?
NCT06553131 is a clinical study titled "Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison". Medications used to relax the muscles are used during surgery. The amount of muscle relaxation can monitored with devices that stimulate a specific nerve and evaluate the muscle response. The response to, and recovery from, medications that relax the muscles are best described for a nerve in the arm...
What is the current status of trial NCT06553131?
This trial is currently recruiting. The enrollment target is 32 participants. The study started on 2024-12-26. Estimated completion is 2026-12.
What conditions does trial NCT06553131 study?
This clinical trial studies the following conditions: Neuromuscular Blockade.
What interventions are being tested in trial NCT06553131?
The interventions under investigation include: Neuromuscular Transmission Monitoring (DEVICE).
Who is sponsoring clinical trial NCT06553131?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06553131 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Blockade
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
RECRUITING · Phase 4
-
NMBA Reversal and Postoperative Urinary Retention
ACTIVE NOT RECRUITING
-
Understanding the Cognition and Decision Making of Community Anesthesiologists
COMPLETED
-
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
COMPLETED · Phase 4
-
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
COMPLETED
-
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.